Cost analysis of the treatments for patients with advanced Parkinson's disease: SCOPE study.

Journal of medical economics

Volumn 16, Issue 2, 2013, Pages 191-201

  Valldeoriola, Francesc ^a   Puig Junoy, Jaume ^b   Puig Peiró, Ruth ^b   Workgroup of the SCOPE study, ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; CARBIDOPA; LEVODOPA;

ARTICLE; BRAIN DEPTH STIMULATION; COMPARATIVE STUDY; COST; ECONOMICS; HEALTH CARE PLANNING; HUMAN; METHODOLOGY; PARKINSON DISEASE; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; SPAIN; UTILIZATION REVIEW;

ANTIPARKINSON AGENTS; CARBIDOPA; COSTS AND COST ANALYSIS; DEEP BRAIN STIMULATION; HEALTH RESOURCES; HUMANS; LEVODOPA; PARKINSON DISEASE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 84877646050     PISSN: None     EISSN: 1941837X     Source Type: None    
DOI: 10.3111/13696998.2012.737392     Document Type: Article

References (0)